Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study

P. Queirolo, B. Dozin, A. Morabito, B. Banelli, P. Piccioli, C. Fava, C. Leo, R. Carosio, S. Laurent, V. Fontana, P.F. Ferrucci, C. Martinoli, E. Cocorocchio, A. Battaglia, P.A. Ascierto, M. Capone, E. Simeone, F. De Galitiis, E. Pagani, G.C.A. CappelliniP. Marchetti, M. Guida, S. Tommasi, M. Mandalà, B. Merelli, P. Quaglino, P. Fava, M. Guidoboni, M. Romani, F. Spagnolo, M.P. Pistillo

Research output: Contribution to journalArticle

Cite this

Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Piccioli, P., Fava, C., Leo, C., Carosio, R., Laurent, S., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Battaglia, A., Ascierto, P. A., Capone, M., Simeone, E., De Galitiis, F., Pagani, E., ... Pistillo, M. P. (2017). Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study. Frontiers in Immunology, 8(APR). https://doi.org/10.3389/fimmu.2017.00386